Nivolumab in Sorafenib-Naive and -Experienced patients with advanced hepatocellular carcinoma (HCC): survival, hepatic safety, and biomarker assessments in CheckMate 040

Autores: Sangro Gómez-Acebo, Bruno Carlos; Melero Bermejo, Ignacio; Yau, T.; Hsu, C.; Kudo, M.; Kim, T. Y.; Choo, S. P.; Trojan, J.; Welling, T. H.; Meyer, T.; Kang, Y. K.; Yeo, W.; Chopra, A.; Baakili, A.; dela Cruz, C.; Zhao, H.; Neely, J.; Crocenzi, T. S.; El-Khoueiry, A. B.